| 1 |
33396366 | Molecular Targeting of VEGF with a Suramin Fragment-DOCA Conjugate by Mimicking the Action of Low Molecular Weight Heparins. | 2020 Dec 31 |
3 |
| 2 |
25168661 | Suramin inhibits the development and progression of peritoneal fibrosis. | 2014 Nov |
1 |
| 3 |
22521862 | Inhibitory effect of 5,8,11-eicosatrienoic acid on angiogenesis. | 2012 Jun |
1 |
| 4 |
19219548 | VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. | 2009 Jul |
1 |
| 5 |
17390169 | Suramin inhibits not only tumor growth and metastasis but also angiogenesis in experimental pancreatic cancer. | 2007 Feb |
3 |
| 6 |
15928663 | Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma. | 2005 Jun 20 |
2 |
| 7 |
16701826 | Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. | 2005 Jul |
1 |
| 8 |
8841939 | Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. | 1996 Jul |
9 |
| 9 |
1719003 | Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. | 1991 Oct |
1 |
| 10 |
1998521 | Specific binding of vascular permeability factor to endothelial cells. | 1991 Feb 28 |
1 |